Record on Satisfaction of Patients With Actonel [risedronic acid] 35 mg Once a Week.

Trial Profile

Record on Satisfaction of Patients With Actonel [risedronic acid] 35 mg Once a Week.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 12 Mar 2010

At a glance

  • Drugs Risedronic acid (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms ROSPA
  • Sponsors Sanofi
  • Most Recent Events

    • 03 Jul 2009 Planned end date added as 1 Sep 2006 as reported by ClinicalTrials.gov.
    • 03 Jul 2009 Actual patient number (7) added as reported by ClinicalTrials.gov.
    • 02 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top